US 5-11 aged children could make vaccination appointment in early Nov.
- Why do Indian Generic Drug Manufacturers Repeatedly Receive Warning Letters from FDA?
- Can Gene Therapy Provide a Cure for HIV?
- More Lethal than Ebola: Germany on High Alert over Marburg Virus Scare
- WHO Approves First Global Monkeypox Vaccine for Adolescents
- Half of Sepsis Patients Die Within Two Years
- Fatigue as the Primary Symptom of Long COVID
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved it on Oct. 26
- Can Gene Therapy Provide a Cure for HIV?
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved it on Oct. 26.
At present, COVID-19 vaccines have been approved for use in people aged 12 and over in the United States, but 28 million elementary school students in the 5-11 age group are still waiting for the approval of Pfizer-BioNTech mRNA vaccine.
On October 18, 2021, the American Children’s Association (AAP) updated the status of COVID-19 infection in children in the United States. In the past week, the United States has added more than 130,000 new cases of COVID-19 in children, accounting for all new cases each week. An increase of 25.5% of cases.
As a result, by October 15, 2021, the number of COVID-19 cases among children in the United States has reached 6.17 million, accounting for 16.4% of all cases and 8.2% of all American children!
At a media conference today (October 20), the Biden administration stated that for 5-11 year-old vaccination, the vaccine has been prepared and is only awaiting approval.
According to regulations, the advisory committee of the US Food and Drug Administration (FDA) is expected to make a decision on whether Pfizer’s mRNA vaccine can be applied to children on October 26, and then the independent advisory committee of the US Centers for Disease Control and Prevention (CDC) will Review and approval from November 2nd to 3rd.
Once both FDA and CDC approve, vaccination can be implemented immediately.
In response, Jeff Zients, the White House COVID-19 response coordinator, said: We have already begun work to deploy vaccination.
For specific vaccination plans, it will be widely deployed, including pediatrician outpatient clinics, other family doctor places, more than 100 children’s hospitals, tens of thousands of pharmacies, and community clinics.
Even considering the medical staff to bring the vaccine to the school, inoculation on the school site.
The vaccine dose for children aged 5-11 years is also different from that for age groups 12 years and older. It is 10ug/dose, which is only 1/3 of the standard dose.
U.S. 5-11 aged children could make vaccination appointment in early Nov. if FDA approved on Oct. 26
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
